CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor

American Journal of Physiology - Endocrinology and Metabolism

Volumn 304, Issue 1, 2013, Pages

  Lee, Wei Yu ^a   Wang, Chun Jen ^a   Lin, Ting Yu ^a   Hsiao, Chih Lun ^a   Luo, Ching Wei ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Endoproteolysis; Macrophages; Stomach

Indexed keywords

ANGIOGENIC FACTOR; ANTIINFLAMMATORY AGENT; CHEMOKINE; CXCL17 CHEMOKINE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN HEK293; CYTOKINE RELEASE; ENDOPROTEOLYSIS; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STOMACH MUCOSA; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CHEMOKINES, CXC; GASTRIC MUCOSA; HEK293 CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTEOLYSIS; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE HOMOLOGY, AMINO ACID; WOUND HEALING;

EID: 84871898671     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00083.2012     Document Type: Article

References (34)

1. Balestrieri ML, Balestrieri A, Mancini FP, Napoli C. Understanding the immunoangiostatic CXC chemokine network. Cardiovasc Res 78: 250-256, 2008.
2. Burkhardt AM, Tai KP, Flores-Guiterrez JP, Vilches-Cisneros N, Kamdar K, Barbosa-Quintana O, Valle-Rios R, Hevezi PA, Zuñiga J, Selman M, Ouellette AJ, Zlotnik A. CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol 188: 6399-6406, 2012.
3. Chesneau V, Pierotti AR, Barré N, Créminon C, Tougard C, Cohen P. Isolation and characterization of a dibasic selective metalloendopeptidase from rat testes that cleaves at the amino terminus of arginine residues. J Biol Chem 269: 2056-2061, 1994.
4. Clark-Lewis I, Kim KS, Rajarathnam K, Gong JH, Dewald B, Moser B, Baggiolini M, Sykes BD. Structure-activity relationships of chemokines. J Leukoc Biol 57: 703-711, 1995.
5. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM. Three-dimensional structure of interleukin 8 in solution. Biochemistry 29: 1689-1696, 1990.
6. Fleetwood AJ, Dinh H, Cook AD, Hertzog PJ, Hamilton JA. GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leukoc Biol 86: 411-421, 2009.
7. Forssmann U, Magert HJ, Adermann K, Escher SE, Forssmann WG. Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/ CCL14a and HCC-2/CCL15. J Leukoc Biol 70: 357-366, 2001.
8. Hiraoka N, Yamazaki-Itoh R, Ino Y, Mizuguchi Y, Yamada T, Hirohashi S, Kanai Y. CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. Gastroenterology 140: 310-321, 2011.
9. Joost P, Methner A. Phylogenetic analysis of 277 human G-protein- coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol 3: RESEARCH0063, 2002.
10. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 135: 41-60, 2008.
11. Malkowski MG, Lazar JB, Johnson PH, Edwards BF. The amino- terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence. J Mol Biol 266: 367-380, 1997.
12. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112: 387-397, 1997.
13. Mu X, Chen Y, Wang S, Huang X, Pan H, Li M. Overexpression of VCC-1 gene in human hepatocellular carcinoma cells promotes cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai) 41: 631-637, 2009.
14. O'Callaghan CA, Tormo J, Willcox BE, Blundell CD, Jakobsen BK, Stuart DI, McMichael AJ, Bell JI, Jones EY. Production, crystallization, and preliminary X-ray analysis of the human MHC class Ib molecule HLA-E. Protein Sci 7: 1264-1266, 1998.
15. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 283: R7-R28, 2002.
16. Peskar BM. Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing. Inflammopharmacology 13: 15-26, 2005.
17. Pisabarro MT, Leung B, Kwong M, Corpuz R, Frantz GD, Chiang N, Vandlen R, Diehl LJ, Skelton N, Kim HS, Eaton D, Schmidt KN. Cutting edge: novel human dendritic cell- and monocyte-attracting chemokine-like protein identified by fold recognition methods. J Immunol 176: 2069-2073, 2006.
18. Proudfoot AE, Peitsch MC, Power CA, Allet B, Mermod JJ, Bacon K, Wells TN. Structure and bioactivity of recombinant human CTAP-III and NAP-2. J Protein Chem 16: 37-49, 1997.
19. Rholam M, Fahy C. Processing of peptide and hormone precursors at the dibasic cleavage sites. Cell Mol Life Sci 66: 2075-2091, 2009.
20. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg 22: 382-389, 1998.
21. Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P. Role of chemokines in endocrine autoimmune diseases. Endocr Rev 28: 492-520, 2007.
22. Sun SC, Hsu PJ, Wu FJ, Li SH, Lu CH, Luo CW. Thyrostimulin, but not thyroid-stimulating hormone (TSH), acts as a paracrine regulator to activate the TSH receptor in mammalian ovary. J Biol Chem 285: 3758-3765, 2010.
23. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 26: 171-176, 1980.
24. Wallace JL, Devchand PR. Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense. Br J Pharmacol 145: 275-282, 2005.
25. Wallace JL, Dicay M, McKnight W, Dudar GK. Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor. Br J Pharmacol 148: 274-278, 2006.
26. Walz A, Dewald B, von Tscharner V, Baggiolini M. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med 170: 1745-1750, 1989.
27. Wang CJ, Hsu SH, Hung WT, Luo CW. Establishment of a chimeric reporting system for the universal detection and high-throughput screening of G protein-coupled receptors. Biosens Bioelectron 24: 2298-2304, 2009.
28. Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 18: 790-804, 2004.
29. Watanabe N, Shimada T, Ohtsuka Y, Hiraishi H, Terano A. Proin- flammatory cytokines and Helicobacter pylori stimulate CC-chemokine expression in gastric epithelial cells. J Physiol Pharmacol 48: 405-413, 1997.
30. Weinstein EJ, Head R, Griggs DW, Sun D, Evans RJ, Swearingen ML, Westlin MM, Mazzarella R. VCC-1, a novel chemokine, promotes tumor growth. Biochem Biophys Res Commun 350: 74-81, 2006.
31. Wu YH, Hu TF, Chen YC, Tsai YN, Tsai YH, Cheng CC, Wang HW. The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. Blood 118: 2896-2905, 2011.
32. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110: 1744-1752, 1996.
33. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, Imanishi J. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 42: 609-617, 1998.
34. Zlotnik A, Yoshie O, Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7: 243, 2006.